GENE ONLINE|News &
Opinion
Blog

Solid Tumor
M&A PfizerSeagen
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
Partnerships Solid Tumor
FDA Clears Exelixis, Sairopa’s SIRPα Antibody For Solid Tumor Trial
2023-02-14
Deals Gilead Sciences
Jounce Sells Anti-CCR8 Antibody to Gilead, Forgoing $645 Million In Milestones
2022-12-28
Trials & Approvals Cancer
First Patient Dosed in Anti-tumor Clinical Trial
2022-07-29
Special Cancer
New Research on Neoantigens and Tumor-targeting T-cells Marks Paradigm Shift in Countering Solid Tumors
2021-11-19
Special Cancer
How Patients with dMMR/MSI-H Tumors Can Benefit from Immunotherapy?
2021-09-24
Special
ESMO21: Experts Debate Whether MRD Diagnosis Can Improve Cure Rates in Solid Tumors
2021-09-17
Trials & Approvals Prostate Cancer
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
R&D
Recent Advances in CAR T-Cell Therapy Development
2021-04-14
R&D
New Strategies to Improve Adoptive Cell Therapies for Solid Tumors
2021-04-14
Trials & Approvals
Clovis Oncology’s PARP Inhibitor Shines in Preliminary Prostate Cancer Trial
2021-04-12
After Five Year Oncology Alliance, Takeda Acquires Maverick to Embark on Solid Tumor Quest
2021-03-10
Funding Solid Tumor
Elevation Oncology Raises $65 M to Repurpose Failed Drug for Genomically Defined Tumors
2020-11-20
R&D KRAS G12C Inhibitor
Mirati’s Successful Targeting of the “Undruggable” Shapes Up Regulatory Showdown with Amgen
2020-10-28
Weekly Asia Highlights- South Korea and Australia
2020-08-13
1 2
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top